Sarana Meditama Metropolitan Tbk PT
IDX:SAME

Watchlist Manager
Sarana Meditama Metropolitan Tbk PT Logo
Sarana Meditama Metropolitan Tbk PT
IDX:SAME
Watchlist
Price: 324 IDR -1.22% Market Closed
Market Cap: Rp5.6T

EV/EBITDA

48.5
Current
31%
Cheaper
vs 3-y median of 70.4

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
48.5
=
Enterprise Value
Rp6.6T
/
EBITDA
Rp128.5B

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
48.5
=
Enterprise Value
Rp6.6T
/
EBITDA
Rp128.5B

Valuation Scenarios

Sarana Meditama Metropolitan Tbk PT is trading below its 3-year average

If EV/EBITDA returns to its 3-Year Average (70.4), the stock would be worth Rp470.52 (45% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-84%
Maximum Upside
+45%
Average Downside
14%
Scenario EV/EBITDA Value Implied Price Upside/Downside
Current Multiple 48.5 Rp324
0%
3-Year Average 70.4 Rp470.52
+45%
5-Year Average 64.1 Rp428.29
+32%
Industry Average 25.3 Rp168.95
-48%
Country Average 7.8 Rp52.14
-84%

Forward EV/EBITDA
Today’s price vs future ebitda

Not enough data available to calculate forward EV/EBITDA

Peer Comparison

All Multiples
EV/EBITDA
P/E
All Countries
Close

Market Distribution

Higher than 87% of companies in Indonesia
Percentile
87th
Based on 706 companies
87th percentile
48.5
Low
0 — 4.4
Typical Range
4.4 — 13.9
High
13.9 —
Distribution Statistics
Indonesia
Min 0
30th Percentile 4.4
Median 7.8
70th Percentile 13.9
Max 1 547 003.1

Sarana Meditama Metropolitan Tbk PT
Glance View

Market Cap
5.6T IDR
Industry
Health Care

PT Sarana Meditama Metropolitan Tbk engages in the provision of healthcare services through the Omni Hospital. The company is headquartered in Jakarta Timur, Dki Jakarta and currently employs 2,581 full-time employees. The company went IPO on 2013-01-11. The firm hospitals are operated under the brand name of EMC Healthcare. The Company’s specialty centers include cardiovascular center, orthopedic center, Kawasaki center, neuroscience center, urology center, oncology surgery center and digestive & bariatric center. The firm operates six hospitals of EMC Hospital Tangerang, EMC Hospital Sentul, EMC Hospital Pulomas, EMC Hospital Alam Sutera, EMC Hospital Cikarang, and EMC Hospital Pekayon. The firm also operates Grha Kedoya Hospital and Grha MM2100 Hospital through subsidiary PT Kedoya Adyaraya Tbk (RSGK). The Company’s subsidiaries include PT Sarana Meditama International, PT Sarana Meditama Anugerah, PT Sarana Meditama Nusantara, PT Kurnia Sejahtera Utama, PT Elang Medika Corpora, PT Sentosa Indah Sejahtera and PT Kedoya Adyaraya Tbk.

SAME Intrinsic Value
174.2 IDR
Overvaluation 46%
Intrinsic Value
Price
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett